Although a significant decrease in HAM-D scores and a significant increase in pro-inflammatory marker (TNF-α) was found from baseline to eight weeks post-treatment, no significant difference was found in anti-inflammatory (IL-10) marker levels across pre-treatment and various post-treatment phases of depression. The gene discussed is IL10; the disease is depressive symptom measurement.